Cite
HARVARD Citation
Koliani-Pace, J. et al. (2019). Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes. Inflammatory bowel diseases. 25 (11), pp. 1854-1861. [Online].